Evidence map›Paper›PMID 29137618›Full record

ArticleBMC biotechnology2017

AFEAP cloning: a precise and efficient method for large DNA sequence assembly.

Fanli Zeng, Jinping Zang, Suhua Zhang, Zhimin Hao, Jingao Dong, Yibin Lin

Open access · goldAbstract read
In one paragraph

Article in BMC biotechnology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Fanli ZengCollege of Life Sciences, Hebei Agricultural University, Baoding, 071001, People's Republic of China.
Jinping ZangCollege of Life Sciences, Hebei Agricultural University, Baoding, 071001, People's Republic of China.
Suhua ZhangInstitute of Biophysics, Hebei University of Technology, Tianjin, 300401, People's Republic of China.
Zhimin HaoCollege of Life Sciences, Hebei Agricultural University, Baoding, 071001, People's Republic of China.
Jingao DongCollege of Life Sciences, Hebei Agricultural University, Baoding, 071001, People's Republic of China. shmdjg@hebau.edu.cn.
Yibin LinMcGovern Medical School, the University of Texas Health Science Center at Houston, Houston, 77030, USA. Yibin.lin@uth.tmc.edu.ORCID http://orcid.org/0000-0003-0608-7875
Hebei Agricultural University · CNHebei University of Technology · CNThe University of Texas Health Science Center · US

Funding

Agricultural University of Hebei ZD201622National Modern Agriculture Industry Technique Systems CARS-02
6 · The paper itself

Abstract

backgroundRecent development of DNA assembly technologies has spurred myriad advances in synthetic biology, but new tools are always required for complicated scenarios. Here, we have developed an alternative DNA assembly method named AFEAP cloning (Assembly of Fragment Ends After PCR), which allows scarless, modular, and reliable construction of biological pathways and circuits from basic genetic parts.

methodsThe AFEAP method requires two-round of PCRs followed by ligation of the sticky ends of DNA fragments. The first PCR yields linear DNA fragments and is followed by a second asymmetric (one primer) PCR and subsequent annealing that inserts overlapping overhangs at both sides of each DNA fragment. The overlapping overhangs of the neighboring DNA fragments annealed and the nick was sealed by T4 DNA ligase, followed by bacterial transformation to yield the desired plasmids.

resultsWe characterized the capability and limitations of new developed AFEAP cloning and demonstrated its application to assemble DNA with varying scenarios. Under the optimized conditions, AFEAP cloning allows assembly of an 8 kb plasmid from 1-13 fragments with high accuracy (between 80 and 100%), and 8.0, 11.6, 19.6, 28, and 35.6 kb plasmids from five fragments at 91.67, 91.67, 88.33, 86.33, and 81.67% fidelity, respectively. AFEAP cloning also is capable to construct bacterial artificial chromosome (BAC, 200 kb) with a fidelity of 46.7%.

conclusionsAFEAP cloning provides a powerful, efficient, seamless, and sequence-independent DNA assembly tool for multiple fragments up to 13 and large DNA up to 200 kb that expands synthetic biologist's toolbox.

Indexed as

Chromosomes, Artificial, BacterialCloning, MolecularDNAPlasmidsPolymerase Chain ReactionSynthetic BiologyDNAAssembly of fragment ends after PCRBacterial artificial chromosomesDNA assemblyMulti-fragment assemblySynthetic biology

Identifiers

PMID29137618
PMCPMC5686892
OpenAlexW2769646093

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.